Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PCSA | Common Stock | Award | +4.39K | +6.45% | 72.5K | Mar 31, 2022 | Direct | F1, F2 | ||
holding | PCSA | Common Stock | 121K | Mar 31, 2022 | by Elion Oncology, Inc. | F2 |
Id | Content |
---|---|
F1 | Vesting of time-based restricted shares. |
F2 | Shares previously reported as indirectly held by Elion Oncology were transferred to the reporting person's direct holdings in a transaction exempt from Section 16 reporting pursuant to Rule 16a-13. |